Iniparib formulations and uses thereof
US11628144B2 · kind B2 · utility
0Cited by
72References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2018 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Sep 28, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are pharmaceutical compositions, formulations, and dosage forms and their use in the treatment of a cancer. Also disclosed herein are methods of treating a cancer in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.